Funding and Investments

May 10, 2011
BioPharm International
By BioPharm International Editors
On Apr. 29, 2011, a federal appeals court has lifted a ban on federal funding for embryonic stem cell (ESC) research. The move was celebrated by researchers hoping to use such cells for research, but it is likely that the decision will be appealed. Embryonic stem cells are pluripotent cells derived from embryonic tissue in a process that usually results in the destruction of the embryo. The ban on funding did not apply to stem cells derived from adult tissue.
Apr 01, 2011
BioPharm International
By BioPharm International Editors
Industry starts the year with a positive spin.
Feb 22, 2011
BioPharm International
By BioPharm International Editors
President's Budget Allocates More Funding to FDA
Jan 01, 2011
BioPharm International
By BioPharm International Editors
Business models that were used to create current value are no longer going to be effective going forward.
Oct 01, 2010
BioPharm International
By BioPharm International Editors
Biotech's mid-sized elites position themselves for growth.
Jul 01, 2010
BioPharm International
By BioPharm International Editors
After a bright start to the year, some of biotech's blue chip companies have seen their early gains turn into losses.
Apr 01, 2010
BioPharm International
By BioPharm International Editors
As the capital markets in the US and globally continue to strengthen, the biotech industry can expect to see a rise in initial public offerings this year.
Oct 01, 2009
BioPharm International
By BioPharm International Editors
Biotech impressed investors with positive drug data, strong drug sales and earnings, and partnering deals.
Aug 01, 2009
BioPharm International
Contract research, development, and manufacturing organizations betting on a comeback in venture capital financing will have a long wait.
Jul 01, 2009
BioPharm International
By BioPharm International Editors
Although the markets closed on a positive note in May, it will still take many more months before biotech starts on the road to full recovery.
native1_300x100
lorem ipsum